Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Sponsor
Dong-A ST Co., Ltd.
Study ID
NCT04326166
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Multi-center, open, non-intervention and observational study to Evaluate the efficacy and safety of Suganon tab. or Sugamet XR tab. in patients with Type 2 diabetes

Key Dates

First listed
Mar 30, 2020
Start date
Mar 25, 2020
Status verified
Mar 2020
Primary completion
Jul 31, 2021
Completion
Jul 31, 2021

Study Design

Enrollment
1,971 participants (estimated)

Arms

  • Arm: Group A
    Patients who receive Double therapy or Insulin
  • Arm: Group B
    Patients who receive DPP-4 inhibitor
  • Arm: Group C
    Drug-naïve patients

Primary Outcome Measure

Change in HbA1c [ Time Frame: at 12 weeks ]

Central Contacts

Related Studies